Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IMATINIB | 400MG | TABLET | Resolved | 2021-02-18 | 2021-03-11 | 134334 |
| TEVA-IMATINIB | 400MG | TABLET | Resolved | 2020-02-07 | 2020-05-08 | 105576 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2022-11-14 | 2023-04-28 | 174613 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2025-05-02 | 2025-05-08 | 256471 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2021-07-15 | 2021-08-13 | 142625 |
| TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2021-03-25 | 2021-04-15 | 136320 |
| TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2020-08-27 | 2020-09-17 | 123087 |
| TEVA-INDOMETHACIN | 50MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-07 | 126924 |
| TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2022-10-17 | 2023-06-09 | 172010 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-04-28 | 2022-07-01 | 159590 |
| TEVA-IPRATROPIUM STERINEBS | 0.025% | SOLUTION | Resolved | 2017-04-25 | 2017-10-10 | 8071 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2020-05-01 | 2020-05-14 | 113764 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-01-20 | 2022-04-21 | 153165 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-02-10 | 2022-07-01 | 154720 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-06-19 | 2023-06-27 | 195618 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-07-11 | 2024-06-20 | 198292 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-10-19 | 2024-06-13 | 207512 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2025-01-09 | 2025-02-06 | 247336 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-04-27 | 2023-06-27 | 190674 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2023-06-08 | 2023-11-03 | 194135 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Discontinued | 2025-03-20 | 2025-03-20 | 253186 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256091 |
| TEVA-FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256137 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |